Important note: Information you find here was accurate in 1998. The state of the art may have changed since the publication date.

BETA is published four times a year by the San Francisco AIDS Foundataion.

Table of Contents

October, 1998

News Briefs
Liz Highleyman

DRUG WATCH: Hydroxyurea
Christopher Gortner

DRUG WATCH: FddA -- Antiretroviral in Development
Leslie Hanna

DRUG WATCH: ABT-378 -- A Second Generation Protease Inhibitor from Abbott
Liz Highleyman

Protease-Sparing Combination Regimens
Ronald Baker, PhD

WOMEN & HIV: Highlights on Women and Pregnancy from the 12th World AIDS Conference
Bruce Mirken

Tuberculosis
Liz Highleyman

CONFERENCE COVERAGE: Vaccine News from the 12th World AIDS Conference
Bruce Mirken

CONFERENCE COVERAGE: Post-Exposure Prophylaxis: Still More Questions than Answers
Bruce Mirken

CONFERENCE COVERAGE: Selected Highlights from the 12th World AIDS Conference
Part 1
Part 2
Part 3
Harvey S. Bartnof, M.D.

Open Clinical Trials for HIV/AIDS Treatments
Katy Stephenson

Glossary
Katy Stephenson

July, 1998

News Briefs
Liz Highleyman

Advocacy
Ronald Baker, PhD

Blood Cell Deficiencies - Part 1
Liz Highleyman

Blood Cell Deficiencies - Part 2
Liz Highleyman

Advertising for AIDS Drugs: It's Everywhere Lately, But Is It Helpful?
Bruce Mirken

Women, Food, and HIV
Lynda E. Bell, RD

Drug Watch: Oxymetholone
Mark Bowers

Drug Watch: FTC -- Antiretroviral in Development
Mark Bowers

Drug Watch: Human Chorionic Gonadotropin - Associated Factor
Mark Bowers

Drug Watch: Cidofovir
Liz Highleyman

Drug Watch: Epoietin alfa (EPO) for Anemia
Leslie Hanna

Open Clinical Trials for HIV/AIDS Treatments
Katy Stephenson

Research Notes: Part 1
Harvey S. Bartnof, MD

Research Notes: Part 2
Harvey S. Bartnof, MD

Research Notes: Part 3
Harvey S. Bartnof, MD

April, 1998

News Briefs
Liz Highleyman

Advocacy
Ron Baker, Ph.D.

DNA and Other Technologies for HIV Vaccines
Mark Bowers

Side Effects Associated with Anti-HIV Drugs
Liz Highleyman

January, 1998

Consumer Rights and Responsibilities
Report to the President of the United States, prepared by the Advisory Commission on Consumer Protection and Quality in the Health Care Industry,

Adherence
Poor adherence by patients is one critical factor that can to drug failure.

Drug Resistance
Viral mutations

Hepatitis
An introduction

AIDS-Related Lymphoma
Research increasingly points to cooperation between or among viruses to produce this kind of cancer.

Complementary and Alternative Medicine
An introduction to Eastern medicine, massage, macrobiotics, biofeedback, and other forms of non-traditional medicine.

Prevention of Mother-to-Child HIV Transmission
Highlights from the Conference on Global Strategies

Mother-to-Child HIV Transmission
Infectious Diseases Society of America Annual Meeting

Conference Highlights
Main themes from various medical conferences

Non-Nucleoside Reverse Transcriptase Inhibitors
Conference highlights

Copyright © 1998 - San Francisco AIDS Foundation. Reproduced by permission. Reproduction of this article (other than one copy for personal reference) must be cleared through BETA: PO Box 426182, San Francisco, CA 94142-6182. Tel: 415 487 8060 Fax: 415 487 8069 URL: http://www.sfaf.org/beta E-mail: beta@sfaf.org

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1990,2001. ÆGiS.